Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q63869281
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000046.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q63869281
|
024
|
|
|
‡a
0000-0003-0836-5875
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q63869281
|
100
|
0 |
|
‡a
Helen E Stevens
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Helen E Stevens
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A Comprehensive, Statistically Powered Analysis of GAD2 in Type 1 Diabetes
|
670
|
|
|
‡a
Author's Analysis of Polymorphisms of the Interleukin-18 Gene in Type 1 Diabetes and Hardy-Weinberg Equilibrium Testing
|
670
|
|
|
‡a
Author's Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
|
670
|
|
|
‡a
Author's Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial.
|
670
|
|
|
‡a
Author's Common Genetic Determinants of Vitamin D Insufficiency: A Genome-Wide Association Study
|
670
|
|
|
‡a
Author's Evidence of association with type 1 diabetes in the SLC11A1 gene region.
|
670
|
|
|
‡a
Author's Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes
|
670
|
|
|
‡a
Author's Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.
|
670
|
|
|
‡a
Author's Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
|
670
|
|
|
‡a
Author's FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
|
670
|
|
|
‡a
Author's Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes
|
670
|
|
|
‡a
Author's Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.
|
670
|
|
|
‡a
Author's Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
|
670
|
|
|
‡a
Author's Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
|
670
|
|
|
‡a
Author's Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes
|
670
|
|
|
‡a
Author's Interaction analysis of the CBLB and CTLA4 genes in type 1 diabetes
|
670
|
|
|
‡a
Author's Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
|
670
|
|
|
‡a
Author's Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2.
|
670
|
|
|
‡a
Author's Parameters for reliable results in genetic association studies in common disease
|
670
|
|
|
‡a
Author's Plasma concentrations of soluble IL-2 receptor α
|
670
|
|
|
‡a
Author's Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients.
|
670
|
|
|
‡a
Author's Postthymic expansion in human CD4 naive T cells defined by expression of functional high-affinity IL-2 receptors
|
670
|
|
|
‡a
Author's PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes
|
670
|
|
|
‡a
Author's Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
|
670
|
|
|
‡a
Author's Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
|
670
|
|
|
‡a
Author's Sequencing and association analysis of the type 1 diabetes-linked region on chromosome 10p12-q11.
|
670
|
|
|
‡a
Author's Seven newly identified loci for autoimmune thyroid disease
|
670
|
|
|
‡a
Author's Shared and distinct genetic variants in type 1 diabetes and celiac disease
|
909
|
|
|
‡a
(orcid) 0000000308365875
‡9
1
|
912
|
|
|
‡a
associationscanof14500nonsynonymoussnpsin4diseasesidentifiesautoimmunityvariants
‡A
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
‡9
1
|
912
|
|
|
‡a
commongeneticdeterminantsofvitamin500insufficiencyagenomewideassociationstudy
‡A
Common Genetic Determinants of Vitamin D Insufficiency: A Genome-Wide Association Study
‡9
1
|
912
|
|
|
‡a
genomewideassociationstudyofcnvsin16000casesof8commondiseasesand3000sharedcontrols
‡A
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
‡9
1
|
919
|
|
|
‡a
localizationoftype1diabetessusceptibilitytothemhcclass1geneshlabandhlaa
‡A
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
‡9
1
|
919
|
|
|
‡a
neonatalandadultrecentthymicemigrantsproduceil8andexpresscomplementreceptorscr1andcr2
‡A
Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2.
‡9
1
|
919
|
|
|
‡a
sharedanddistinctgeneticvariantsintype1diabetesandceliacdisease
‡A
Shared and distinct genetic variants in type 1 diabetes and celiac disease
‡9
1
|
919
|
|
|
‡a
7newlyidentifiedlociforautoimmunethyroiddisease
‡A
Seven newly identified loci for autoimmune thyroid disease
‡9
1
|
919
|
|
|
‡a
sequencingandassociationanalysisofthetype1diabeteslinkedregiononchromosome10p12q11
‡A
Sequencing and association analysis of the type 1 diabetes-linked region on chromosome 10p12-q11.
‡9
1
|
919
|
|
|
‡a
robustassociationsof4newchromosomeregionsfromgenomewideanalysesoftype1diabetes
‡A
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
‡9
1
|
919
|
|
|
‡a
regulatorytcellresponsesinparticipantswithtype1diabetesafterasingledoseofinterleukin2anonrandomisedopenlabeladaptivedosefindingtrial
‡A
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
‡9
1
|
919
|
|
|
‡a
ptpn22trp620explainstheassociationofchromosome1p13withtype1diabetesandshowsastatisticalinteractionwithhlaclass2genotypes
‡A
PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes
‡9
1
|
919
|
|
|
‡a
postthymicexpansioninhumancd4naivetcellsdefinedbyexpressionoffunctionalhighaffinityil2receptors
‡A
Postthymic expansion in human CD4 naive T cells defined by expression of functional high-affinity IL-2 receptors
‡9
1
|
919
|
|
|
‡a
plasmaconcentrationsofsolubleil2receptorαcd25areincreasedintype1diabetesandassociatedwithreduced100peptidelevelsinyoungpatients
‡A
Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients.
‡9
1
|
919
|
|
|
‡a
comprehensivestatisticallypoweredanalysisofgad2intype1diabetes
‡A
A Comprehensive, Statistically Powered Analysis of GAD2 in Type 1 Diabetes
‡9
1
|
919
|
|
|
‡a
plasmaconcentrationsofsolubleil2receptorα
‡A
Plasma concentrations of soluble IL-2 receptor α
‡9
1
|
919
|
|
|
‡a
analysisofpolymorphismsoftheinterleukin18geneintype1diabetesandhardyweinbergequilibriumtesting
‡A
Analysis of Polymorphisms of the Interleukin-18 Gene in Type 1 Diabetes and Hardy-Weinberg Equilibrium Testing
‡9
1
|
919
|
|
|
‡a
capturingthesystemicimmunesignatureofanorovirusinfectionannof1casestudywithinaclinicaltrial
‡A
Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial.
‡9
1
|
919
|
|
|
‡a
evidenceofassociationwithtype1diabetesintheslc11a1generegion
‡A
Evidence of association with type 1 diabetes in the SLC11A1 gene region.
‡9
1
|
919
|
|
|
‡a
evidenceofgenegeneinteractionandageatdiagnosiseffectsintype1diabetes
‡A
Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes
‡9
1
|
919
|
|
|
‡a
evidencethathlaclass1and2associationswithtype1diabetesautoantibodiestogadandautoantibodiestoia2aredistinct
‡A
Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.
‡9
1
|
919
|
|
|
‡a
finemappingoftype1diabetessusceptibilitylociandevidenceforcolocalizationofcausalvariantswithlymphoidgeneenhancers
‡A
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
‡9
1
|
919
|
|
|
‡a
fut2nonsecretorstatuslinkstype1diabetessusceptibilityandresistancetoinfection
‡A
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
‡9
1
|
919
|
|
|
‡a
geneticassociationanalysesofatopicillnessandproinflammatorycytokinegeneswithtype1diabetes
‡A
Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes
‡9
1
|
919
|
|
|
‡a
genomewideassociationanalysisofautoantibodypositivityintype1diabetescases
‡A
Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.
‡9
1
|
919
|
|
|
‡a
genomewideassociationstudyandmetaanalysisfindthatover40lociaffectriskoftype1diabetes
‡A
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
‡9
1
|
919
|
|
|
‡a
inheritedvariationinvitamin500genesisassociatedwithpredispositiontoautoimmunediseasetype1diabetes
‡A
Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes
‡9
1
|
919
|
|
|
‡a
parametersforreliableresultsingeneticassociationstudiesincommondisease
‡A
Parameters for reliable results in genetic association studies in common disease
‡9
1
|
919
|
|
|
‡a
interactionanalysisofthecblbandctla4genesintype1diabetes
‡A
Interaction analysis of the CBLB and CTLA4 genes in type 1 diabetes
‡9
1
|
996
|
|
|
‡2
LC|n 2023024523
|
996
|
|
|
‡2
LC|n 88670156
|
996
|
|
|
‡2
ISNI|0000000022310182
|
996
|
|
|
‡2
CAOONL|ncf10028613
|
996
|
|
|
‡2
ISNI|0000000499861109
|
996
|
|
|
‡2
BIBSYS|13025369
|
996
|
|
|
‡2
SUDOC|075450194
|
996
|
|
|
‡2
SUDOC|183714407
|
996
|
|
|
‡2
BIBSYS|2008099
|
996
|
|
|
‡2
NTA|326216189
|
996
|
|
|
‡2
ISNI|0000000063991199
|
996
|
|
|
‡2
NTA|151127093
|
996
|
|
|
‡2
NTA|240149378
|
996
|
|
|
‡2
LC|n 79019945
|
996
|
|
|
‡2
NTA|067729258
|
996
|
|
|
‡2
SUDOC|144286963
|
996
|
|
|
‡2
CAOONL|ncf11343257
|
996
|
|
|
‡2
SUDOC|178048658
|
996
|
|
|
‡2
DNB|133077349
|
996
|
|
|
‡2
SUDOC|070167702
|
996
|
|
|
‡2
NTA|072428031
|
996
|
|
|
‡2
LC|nb2013015332
|
996
|
|
|
‡2
BIBSYS|90654981
|
996
|
|
|
‡2
ISNI|0000000363944693
|
996
|
|
|
‡2
ISNI|0000000035631620
|
996
|
|
|
‡2
ISNI|0000000393125541
|
996
|
|
|
‡2
LC|nb2002036588
|
996
|
|
|
‡2
SUDOC|131685007
|
996
|
|
|
‡2
ISNI|0000000029402725
|
996
|
|
|
‡2
PLWABN|9810587423205606
|
996
|
|
|
‡2
CAOONL|ncf11601066
|
996
|
|
|
‡2
ISNI|0000000390822990
|
996
|
|
|
‡2
LC|no2012147326
|
996
|
|
|
‡2
LC|n 2007024625
|
996
|
|
|
‡2
LC|no 96006484
|
996
|
|
|
‡2
LC|no2018160745
|
996
|
|
|
‡2
LC|no2007095587
|
996
|
|
|
‡2
ISNI|0000000398578144
|
996
|
|
|
‡2
ISNI|0000000114481819
|
996
|
|
|
‡2
LC|n 2007019265
|
996
|
|
|
‡2
ISNI|0000000083064595
|
996
|
|
|
‡2
J9U|987007283322305171
|
996
|
|
|
‡2
ISNI|0000000394153536
|
996
|
|
|
‡2
ISNI|0000000388950635
|
996
|
|
|
‡2
LC|no2012021887
|
996
|
|
|
‡2
LC|n 84017568
|
996
|
|
|
‡2
LC|nb2018014117
|
996
|
|
|
‡2
ISNI|0000000031258427
|
996
|
|
|
‡2
J9U|987007423000505171
|
996
|
|
|
‡2
NTA|138274711
|
996
|
|
|
‡2
LC|n 95111010
|
996
|
|
|
‡2
NTA|120797380
|
996
|
|
|
‡2
SUDOC|084344733
|
996
|
|
|
‡2
SUDOC|265954355
|
996
|
|
|
‡2
SUDOC|244223068
|
996
|
|
|
‡2
BNF|14418063
|
996
|
|
|
‡2
ICCU|CUBV045166
|
996
|
|
|
‡2
BNF|16588652
|
996
|
|
|
‡2
BIBSYS|90572802
|
996
|
|
|
‡2
CAOONL|ncf11903789
|
996
|
|
|
‡2
ISNI|0000000021880482
|
996
|
|
|
‡2
DNB|127375937
|
996
|
|
|
‡2
LC|no 95038339
|
996
|
|
|
‡2
LC|n 90719750
|
996
|
|
|
‡2
NTA|43828951X
|
996
|
|
|
‡2
NTA|071601457
|
996
|
|
|
‡2
RERO|A003864219
|
996
|
|
|
‡2
ISNI|0000000439638511
|
996
|
|
|
‡2
BIBSYS|4098104
|
996
|
|
|
‡2
LC|no 98122501
|
996
|
|
|
‡2
LC|n 93066565
|
996
|
|
|
‡2
PTBNP|1359333
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|